Abstract:Background Mechanical heart valve replacement (MHVR) is an effective method for the treatment of severe heart valve disease; however, it subjects patient to lifelong warfarin therapy after MHVR with the attendant risk of bleeding and thrombosis. Whether internet-based warfarin management reduces complications and improves patient quality of life remains unknown. Objective This study aimed to compare the effects of internet-based warfarin management and the conventional approach in patients who received MHVR in order to provide evidence regarding alternative strategies for long-term anticoagulation. Methods This was a prospective, multicenter, randomized, open-label, controlled clinical trial with a 1-year follow-up. Patients who needed long-term warfarin anticoagulation after MHVR were enrolled and then randomly divided into conventional and internet-based management groups. The percentage of time in the therapeutic range (TTR) was used as the primary outcome, while bleeding, thrombosis, and other events were the secondary outcomes. Results A total of 721 patients were enrolled. The baseline characteristics did not reach statistical differences between the 2 groups, suggesting the random assignment was successful. As a result, the internet-based group showed a significantly higher TTR (mean 0.53, SD 0.24 vs mean 0.46, SD 0.21; P<.001) and fraction of time in the therapeutic range (mean 0.48, SD 0.22 vs mean 0.42, SD 0.19; P<.001) than did those in the conventional group. Furthermore, as expected, the anticoagulation complications, including the bleeding and embolic events had a lower frequency in the internet-based group than in the conventional group (6.94% vs 12.74%; P=.01). Logistic regression showed that internet-based management increased the TTR by 7% (odds ratio [OR] 1.07, 95% CI 1.05-1.09; P<.001) and reduced the bleeding and embolic risk by 6% (OR 0.94, 95% CI 0.92-0.96; P=.01). Moreover, low TTR was found to be a risk factor for bleeding and embolic events (OR 0.87, 95% CI 0.83-0.91; P=.005). Conclusions The internet-based warfarin management is superior to the conventional method, as it can reduce the anticoagulation complications in patients who receive long-term warfarin anticoagulation after MHVR. Trial Registration Chinese Clinical Trial Registry ChiCTR1800016204; http://www.chictr.org.cn/showproj.aspx?proj=27518 International Registered Report Identifier (IRRID) RR2-10.1136/bmjopen-2019-032949

[Clinical Study of Anticoagulation with Warfarin and Heparin in Patients after Mechanical Valve Replacement].

Clinical Research of Oral Anticoagulant Therapy by Warfarin for the Patients with Mechanical Heart Valve Prostheses

The Anticoagulation and Monitoring after the Valve Replacement Opreation

The Anticoagulant Therapy and International Normalized Ratio Monitoring after the Mechanical Heart Valve Replacement

Efficacy Observation of Bridging Anticoagulation of Low Molecular Weight Heparin after Cardic Valve Replacement in the Early Stage

Anticoagulation of Warfarin Therapy in Patients after Mechanical Valve Implantation

[Low intensity anticoagulation therapy after mechanical heart valve replacement].

The observation and clinical significance of the long-term anticoagulation status in patients after mechanical heart valve replacement.

Strategy of Warfarin Adjustment after Mechanical Heart Valve Replacement

Clinical study of the appropriate range of warfarin anticoagulant therapy intensity in patients after heart valve replacement

Influences of Different Anticoagulant Intensity on Coagulation Activation in Patients after Mechanical Valve Replacement

Anticoagulation Management Of Patients With Long-Term Warfarin Therapy After Valve Replacement During The Perioperative Period Of Pacemaker Implantation

Comparison of Different Bridging Anticoagulation Therapies Used after Mechanical Heart Valve Replacement in Chinese Patients-a Prospective Cohort Study

Study of the Warfarin-Associated Bleeding after Mechanical Prosthetic Valve Replacement

Therapeutic Monitoring Anticoagulation of Warfarin in Patients with Prosthetic Heart Valve Replacement

Application and Monitoring of Anticoagulation after Heart Valve Replacement

[Anticoagulation in Chinese Patients with Carbomedics Mechanical Prosthetic Heart Valves].

Clinical analysis of anticoagulant therapy with low intensity after mechanical heart valve replacement

New Internet-Based Warfarin Anticoagulation Management Approach After Mechanical Heart Valve Replacement: Prospective, Multicenter, Randomized Controlled Trial

Choice of perioperative anticoagulation for patients of long-term warfalin therapy after valve replacement during device implantation

Low-dose Anticoagulation in Chinese Patients with Mechanical Heart Valves.